0 (0%) | 02-06 12:19 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 7.35 | 1-year : | 8.59 |
Resists | First : | 6.3 | Second : | 7.35 |
Pivot price | 5.49 ![]() |
|||
Supports | First : | 4.86 ![]() |
Second : | 3.98 ![]() |
MAs | MA(5) : | 5.71 ![]() |
MA(20) : | 5.45 ![]() |
MA(100) : | 5.35 ![]() |
MA(250) : | 5.87 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 87.1 ![]() |
D(3) : | 79.3 ![]() |
RSI | RSI(14): 59.1 ![]() |
|||
52-week | High : | 8.86 | Low : | 3.96 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ OBIO ] has closed below upper band by 6.0%. Bollinger Bands are 23.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 6.17 - 6.19 | 6.19 - 6.21 |
Low: | 5.69 - 5.72 | 5.72 - 5.74 |
Close: | 5.93 - 5.98 | 5.98 - 6.02 |
Wed, 05 Feb 2025
Obio/Akpor chapter, a new ICAN district, to promote professional development, members health - Businessday
Wed, 05 Feb 2025
Medtronic M&A Veteran Who Led $60B+ in Deals Joins Orchestra BioMed Board - StockTitan
Thu, 02 Jan 2025
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model - Investing.com
Wed, 18 Dec 2024
Here's Why We're Watching Orchestra BioMed Holdings' (NASDAQ:OBIO) Cash Burn Situation - Simply Wall St
Tue, 03 Dec 2024
OBIO® Celebrates 15th Anniversary With Fresh New Look - Business Wire
Tue, 12 Nov 2024
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 38 (M) |
Held by Insiders | 1.758e+007 (%) |
Held by Institutions | 22 (%) |
Shares Short | 703 (K) |
Shares Short P.Month | 0 (K) |
EPS | -5.981e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -1 % |
Return on Assets (ttm) | 655.7 % |
Return on Equity (ttm) | -39.3 % |
Qtrly Rev. Growth | 2.65e+006 % |
Gross Profit (p.s.) | 330.73 |
Sales Per Share | -223.57 |
EBITDA (p.s.) | 5.97561e+006 |
Qtrly Earnings Growth | -1.7 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -48 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.03 |
Price to Cash Flow | 1.99 |
Dividend | 0 |
Forward Dividend | 736730 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |